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Activation of Epidermal Toll-Like Receptor 2 Enhances
Tight Junction Function: Implications for Atopic
Dermatitis and Skin Barrier Repair
I-Hsin Kuo1,2, Amanda Carpenter-Mendini1, Takeshi Yoshida1, Laura Y. McGirt3, Andrei I. Ivanov4,10,
Kathleen C. Barnes5, Richard L. Gallo6, Andrew W. Borkowski6, Kenshi Yamasaki7, Donald Y. Leung8,
Steve N. Georas9, Anna De Benedetto1 and Lisa A. Beck1
Atopic dermatitis (AD) is characterized by epidermal tight junction (TJ) defects and a propensity for
Staphylococcus aureus skin infections. S. aureus is sensed by many pattern recognition receptors, including
Toll-like receptor 2 (TLR2). We hypothesized that an effective innate immune response will include skin barrier
repair, and that this response is impaired in AD subjects. S. aureus–derived peptidoglycan (PGN) and synthetic
TLR2 agonists enhanced TJ barrier and increased expression of TJ proteins, claudin-1 (CLDN1), claudin-23
(CLDN23), occludin, and Zonulae occludens 1 (ZO-1) in primary human keratinocytes. A TLR2 agonist enhanced
skin barrier recovery in human epidermis wounded by tape stripping. Tlr2 / mice had a delayed and
incomplete barrier recovery following tape stripping. AD subjects had reduced epidermal TLR2 expression as
compared with nonatopic subjects, which inversely correlated (r¼  0.654, P¼ 0.0004) with transepidermal water
loss (TEWL). These observations indicate that TLR2 activation enhances skin barrier in murine and human skin
and is an important part of a wound repair response. Reduced epidermal TLR2 expression observed in AD
patients may have a role in their incompetent skin barrier.
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INTRODUCTION
Recent findings have solidified the notion that skin
barrier dysfunction has a key role in the initiation of
atopic dermatitis (AD). Dysfunction of the skin barrier in
AD can occur through both genetic and acquired mechan-
isms. For example, AD subjects may have a loss-of-function
mutation in filaggrin (Cork et al., 2006; Palmer et al.,
2006; Howell et al., 2009), epidermal lipid abnormalities
(Murata et al., 1996; Imokawa, 2001; Pilgram et al., 2001),
altered protease activity (Cork et al., 2006; Vasilopoulos et al.,
2007), more alkaline surface pH (Elias et al., 2008), and a
defect in tight junction (TJ) function (De Benedetto et al.,
2011), all of which can contribute to decreased skin barrier
function.
The human epidermis is a multilayered structure that is
made up of four progressively differentiated layers. Transient
breaches in skin barrier that might occur with topical exposure
to organic solvents or detergents, scratching, and endogenous
or exogenous proteases (e.g., from allergens or microbes) can
temporally disrupt our skin barrier. In healthy subjects, the
barrier repair mechanisms normally prevent or minimize the
potential for pathogens or allergens to penetrate the host and
evoke an immune response. An inadequate barrier repair
response would lead to enhanced and more prolonged
allergen sensitization, microbial colonization, and/or infec-
tion, in addition to greater transepidermal water loss (TEWL)
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that leads to skin xerosis (Grigoryev et al., 2010; Boguniewicz
and Leung, 2011; De Benedetto et al., 2012; Kubo et al.,
2012). All these are well-recognized features of AD.
The function of innate receptors, conventionally recognized
for their antimicrobial effects, has recently been extended to
include epithelial barrier regulation (Cario et al., 2004, 2007;
Rezaee et al., 2011; Yuki et al., 2011b). Toll-like receptor 2
(TLR2) has received the greatest attention, as it is important for
immune responses to a number of microbes, such as
Staphylococcus aureus and herpes simplex virus (Takeuchi
et al., 1999, 2000; Sato et al., 2006; Bochud et al., 2007;
Zahringer et al., 2008; De Benedetto et al., 2009), that more
commonly colonize and/or infect the skin of AD patients
(Boguniewicz and Leung, 2010; Ong and Leung, 2010).
Several groups have shown that AD patients have reduced
expression and/or function of TLR2 on their monocytes and
macrophages (Hasannejad et al., 2007; Niebuhr et al., 2009).
However, the role of TLR2 in modulating epidermal barrier
in vitro and in vivo remains poorly understood. In this study,
we observed a reduction of TLR2 expression in AD skin
epithelium. In addition, we observed that TLR2 signaling
enhances the TJ integrity in cultured keratinocytes, which is
in part mediated by enhanced expression of key TJ proteins.
This TLR2 barrier repair effect was also confirmed in the TLR2-
deficient mouse and in a human wound model. We conclude
that TLR2 is important for the maintenance of TJ integrity in
response to barrier insults, and that this barrier repair
mechanism may be defective in AD subjects. The
consequence of this defect might explain why these patients
are susceptible to microbial colonization and infections of the
skin, which are thought to perpetuate their chronic skin
inflammation.
RESULTS
TLR2 agonists enhance TJ function and increase the expression of
TJ proteins
Several studies have suggested that the antimicrobial barrier
and stratum corneum (SC) permeability barrier are coregulated
(Aberg et al., 2008; Ahrens et al., 2011; Borkowski and Gallo,
2011; Grether-Beck et al., 2012). We hypothesized that the
crosstalk between innate immunity and barrier integrity may
extend to TJs, the other epidermal barrier structure important
in regulating paracellular permeability of ions and
macromolecules. Specifically, we wondered whether
epidermal TJ permeability could be regulated by relevant
cutaneous pathogens such as S. aureus. To test this hypothesis,
primary human keratinocytes (PHKs) were stimulated with
S. aureus–derived peptidoglycan (PGN) and lipoteichoic acid
(LTA) (Figure 1a and b). PGN significantly increased the
transepithelial electrical resistance (TEER) of PHK monolayers
in a dose-dependent manner. In contrast, LTA had no effect on
TJ barrier function, despite evidence that it could enhance the
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Figure 1. Toll-like receptor 2 (TLR2) agonists enhance tight junction (TJ) function in primary human keratinocytes (PHKs). Transepithelial electrical resistance
(TEER) was measured daily until day 8 in PHKs stimulated with (a) Staphylococcus aureus–derived peptidoglycan (PGN, n¼ 3–7), (b) S. aureus–derived
lipoteichoic acid (LTA, n¼ 3), (c) Pam3CSK4, a TLR1/2 ligand (n¼ 3–6), (d) Malp-2, a TLR2/6 ligand (n¼ 5), (e) lipopolysaccharide (LPS), a TLR4 ligand (n¼3),
and (f) polyinosinic-polycytidylic acid (polyI:C), a TLR3 ligand (n¼3–9). Malp-2, macrophage-activating lipopeptide-2; Pam3CSK4, N-palmitoyl-S-[2,3-
bis(palmitoyl)-(2RS)-propyl]-(R)cysteinyl-alanyl-glycine. Data are presented as the mean±SEM by analyzing the area under the TEER curve normalized to the mean
values for the control group (media alone). (g) PHKs grown on Transwell inserts were stimulated with the indicated concentrations of S. aureus–derived PGN,
Pam3CSK4, and Malp-2 for 48 hours and paracellular flux measured and compared with media alone. Data are expressed as a fold of media alone group; n¼ 3;
*Po0.05; **Po0.01; ***Po.001. NS, not significant.
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expression of TLR2, cluster of differentiation 14, peptidoglycan
recognition protein 3 (PGLYRP-3), and human b-defensin 2 in
human keratinocytes (data not shown). Using synthetic ligands
targeting specific TLR2 heterodimers, Pam3CSK4 (N-palmi-
toyl-S-[2,3-bis(palmitoyl)-(2RS)-propyl]-(R)cysteinyl-alanyl-gly-
cine; a TLR1/2 agonist) and Malp-2 (macrophage-activating
lipopeptide-2; a TLR2/6 agonist), we found that both increased
keratinocyte TEER in a dose-dependent manner (Pam3CSK4:
Po0.05; Malp-2: Po0.05; Figure 1c and d). In contrast,
lipopolysaccharide (LPS), a TLR4 agonist, had no effect on
TJ barrier integrity even at high concentrations (Figure 1e),
which may reflect the low TLR4 expression on human
PHKs (data not shown) (Baker et al., 2003; Mempel et al.,
2003; Kollisch et al., 2005). Interestingly, polyinosinic-
polycytidylic acid, a synthetic TLR3 agonist, appeared to
consistently enhance epidermal TJ barrier in a wide range
of concentrations (0.01–10mg ml1) but with substantial
variability among PHK preparations (Figure 1f). To examine
whether TLR2 agonists affect epithelial permeability for larger
molecules, we measured paracellular flux of fluorescein
(Figure 1g). Incubation of PHK monolayers with natural
(PGN) and synthetic TLR2 agonists (Pam3CSK4 and Malp-2)
for 24 hours significantly decreased their permeability to
fluorescein. Collectively, the TEER and paracellular flux
data demonstrate that TLR2 signaling enhances TJ barrier
function, which nicely complements its other innate defense
actions.
To examine whether barrier-enhancing effects of TLR2
agonists are associated with altered expression of TJ pro-
teins, we quantified the expression of key transmembrane
and cytosolic TJ components in cultured keratinocytes
(Lucke et al., 1999; Amagai et al., 2000; Furuse et al.,
2001, 2002; Baltes et al., 2004; Kretz et al., 2004; Ma et al.,
2004; Tunggal et al., 2005; Djalilian et al., 2006; Gareus
et al., 2007; Ohnemus et al., 2008; Yuki et al., 2011a).
We found that mRNA expression of claudin-1 (CLDN1),
claudin-23 (CLDN23), occludin, and Zonulae occludens 1
(ZO-1) was significantly (Po0.01) induced after 24 hours of
stimulation of confluent PHKs with PGN, whereas the
expression of adherens junction, gap junction, and
desmosomal proteins was not significantly affected
(Supplementary Figure S1 online). We confirmed these
quantitative PCR findings at the protein level by western
blot analysis (Figure 2a). TLR2 synthetic agonists (Pam3CSK4
and Malp-2) also enhanced the protein expression of
CLDN1, occludin, ZO-1, and CLDN23. It is noteworthy
that LTA, which had no effect on TJ function, also had no
effect on the protein expression of key TJ components
(Figure 2b). Quantified western blot results are shown in
Supplementary Figure S2 online.
The integrity of epithelial barrier depends not only on the
total level of TJ proteins, but also on their ability to form
complexes at the plasma membrane. Therefore, we performed
cell fractionation to evaluate the effect of TLR2 signaling on
localization of integral membrane TJ proteins (Utech et al.,
2005; Marchiando et al., 2010). We found that CLDN1,
occludin, and CLDN23 accumulated exclusively in the
membrane fraction and their level at the membrane was
enhanced by PGN stimulation (Figure 2c). The specificity of
our cellular fractionation was confirmed using appropriate
markers (Supplementary Figure S3 online).
Blocking TLR2 prevents PGN-mediated effects on TJ
S. aureus–derived PGN can be sensed by several innate
receptors including TLR2, NOD2 (nucleotide-binding oligomer-
ization domain-containing 2), and PGLYRPs. To confirm that
the enhanced barrier function and increased expression of TJ
protein in PHK monolayers stimulated with PGN was TLR2
dependent, we conducted blocking experiments using a specific
TLR2-neutralizing antibody. As compared with isotype-matched
control, the TLR2-neutralizing antibody completely inhibited
the PGN-induced increase in TEER (Po0.01; Figure 3a) and
decrease in paracellular flux (Po0.01; Figure 3b). In addition,
blocking TLR2 signaling abrogated the PGN-dependent upre-
gulation of TJ components, CLDN1, occludin, ZO-1, and
CLDN23, both at the mRNA (Figure 3c) and protein
(Figure 3d and Supplementary Figure S2b online) levels.
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Figure 2. Toll-like receptor 2 (TLR2) agonists induce tight junction (TJ)
protein expression and subcellular localization. Primary human keratinocytes
(PHKs) were treated with (a) Staphylococcus aureus–derived peptidoglycan
(PGN; 0.2, 2, and 20mg ml 1), Pam3CSK4 (0.1, 1, and 10mg ml 1), Malp-2
(10, 100, and 1,000 ng ml1), and (b) lipoteichoic acid (LTA; 1 and
10mg ml1) for 48 hours, and claudin-1 (CLDN1), occludin, Zonulae
occludens 1 (ZO-1), and claudin-23 (CLDN23) protein levels were detected
from whole-cell lysates by western blot analysis. Malp-2, macrophage-
activating lipopeptide-2; Pam3CSK4, N-palmitoyl-S-[2,3-bis(palmitoyl)-(2RS)-
propyl]-(R)cysteinyl-alanyl-glycine. Quantitative protein expression was
determined by densitometry of bands after normalization to the housekeeping
protein (b-actin). (c) Membrane and cytosolic protein lysates were made and TJ
proteins were detected by western blot analysis after treating PHKs with PGN
(20mg ml1) for 48 hours. Representative blot of n¼3 experiments.
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A TLR2 agonist enhances human skin barrier repair
A classic hallmark of AD is a chronic itch/scratch cycle that
leads to persistent barrier disruption. To mimic this mechani-
cally induced barrier disruption (Taljebini et al., 1996;
Koschwanez and Broadbent, 2011), we performed tape
stripping in human discarded skins. TJ barrier recovery was
monitored by measuring TEER and the paracellular fluorescein
flux using the modified micro-Snapwell system with and
without Pam3CSK4 treatment (see Materials and Methods
and Figure 4a). Interestingly, treatment with the TLR1/2
agonist significantly enhanced TEER recovery (1.4-fold,
Po0.004; Figure 4b) and resulted in an B50% decrease in
the paracellular flux (P¼0.007; Figure 4c) at 24 hours after
wounding.
TLR2 knockout (Tlr2 / ) mice have a delayed and incomplete
recovery of skin barrier function
To further clarify the importance of TLR2 in epidermal barrier
repair in vivo, we utilized a tape-stripping wound model in
wild type (WT) and Tlr2 / mice, and monitored barrier
recovery by measuring TEWL. In WT mice, the skin barrier
fully recovered 24 hours after tape stripping, whereas Tlr2 /
mice had a substantially slower recovery rate and did not
reach baseline values even 24 hours after wounding
(Figure 4d). At 2 hours after skin barrier disruption, the mRNA
expression of cldn1 and zo-1 were slightly but significantly
increased in WT but not in Tlr2 / mice, whereas cldn2, a
pore-forming TJ protein, was increased in Tlr2 / mice
(Supplementary Figure S4 online). Because TEWL measure-
ment is an in vivo barrier assay that may reflect the integrity of
both epidermal barrier structures (SC and TJ) as well as dermal
blood flow, we used our developed micro-Snapwell system to
clarify whether the changes we observed in TEWL were at
least in part reflected in functional changes in TJ ex vivo.
To determine whether TLR2 agonists affect TJ integrity in this
wound model, we measured TEER using the modified micro-
Snapwell system in murine epidermis with and without
Pam3CSK4 treatment. Pam3CSK4 significantly enhanced TEER
over media alone 24 hours after wounding in the WT mice
(P¼ 0.029). This effect was not observed in wounded
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Figure 3. Toll-like receptor 2 (TLR2)-neutralizing antibody inhibited Staphylococcus aureus–derived peptidoglycan (PGN) effect on tight junction (TJ) protein
function and expression. (a) Transepithelial electrical resistance (TEER; n¼ 5) and (b) paracellular flux (n¼5) measurement at 48 hours (day 2) in primary human
keratinocytes (PHKs) treated with PGN (20mg ml1) and/or TLR2-neutralizing antibody (10mg ml 1). Data are normalized to the control group (IgG2b treatment).
(c) TJ mRNA (n¼3) and (d) protein expression (representative blot of n¼ 3 experiments) was observed in response to treatment with PGN (20mg ml 1, 24 or
48 hours, respectively) with or without TLR2-neutralizing antibody (5mg ml1). The expression was quantified by densitometry of bands and normalization to
the housekeeping protein (b-actin). CLDN1, claudin-1; CLDN23, claudin-23; ZO-1, Zonulae occludens 1. *Po0.05; **Po0.01; ***Po0.001; #compared
IgG2bþPGN with TLR2Abþ PGN.
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epidermis from Tlr2 / mice (Figure 4e). Collectively, these
results indicate that TLR2 agonist enhances TJ barrier recovery
in human and murine epidermal wound models.
AD subjects have reduced epidermal expression of TLR1 and
TLR2
Keratinocytes respond to S. aureus using multiple innate
receptors that reside on the cell membrane (TLRs 1, 2, and
6), are intracellular (NOD2), or are secreted (PGLYRP-3 and
PGLYRP-4). We hypothesized that the expression of one or
more of these key receptors may be reduced in AD, which
could explain altered barrier repair responses and the suscept-
ibility of AD subjects to S. aureus colonization. To test this
hypothesis, epidermal samples were taken from non-sun-
exposed volar forearms to control for anatomical differences
and photo-induced changes from well-characterized subjects
with AD and nonatopic controls. We initially quantified the
mRNA expression for different innate receptors in epidermal
samples using quantitative PCR. Both epidermal TLR1, which
heterodimerizes with TLR2, and TLR2 mRNA were signifi-
cantly decreased (P¼0.03 and 0.04, respectively) in AD
subjects. Expression levels of TLR6, NOD2, PGLYRP-3, and
PGLYRP-4 were similar in the two groups (Figure 5). The
reduced TLR2 expression was confirmed at the protein level
by immunofluorescence staining (Figure 6a). Epidermal TLR2
staining was significantly reduced in all AD samples (nonle-
sional and lesional; median intensity: 76 and 52, P¼0.01,
P¼0.0005, respectively) as compared with nonatopic
samples (median intensity: 96; Figure 6b). Interestingly, PHKs
isolated from AD epidermis have a reduced inflammatory
response (tumor necrosis factor-a (TNF-a), IL-6, and human
b-defensin 2; Pr 0.032) to PGN (Supplementary Figure S7
online).
TLR2 protein expression inversely correlated with TEWL
To address whether TLR2 epidermal expression might be a
determinant of skin barrier function, we evaluated the relation-
ship between TLR2 staining intensity and TEWL, a functional
measurement of skin barrier integrity (Figure 6c). Epidermal
TLR2 immunoreactivity demonstrated a significant inverse
correlation with TEWL (r¼  0.654, P¼ 0.0004). We also
observed that mRNA expression for both TLR1 and TLR2
correlated inversely with TEWL (Supplementary Figure S5
online). In summary, these observations strongly suggest
that the decreased expression of key innate receptors, TLR1
and TLR2, may adversely affect integrity of the epidermal
barrier.
DISCUSSION
Epidermal TJs form the barrier preventing paracellular move-
ment between different cell layers of the stratum granulosum.
TJs are very dynamic structures, loosening and tightening in
response to endogenous signals that originate from epithelial
and subepithelial compartments, as well as exogenous agents
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such as bacterial-derived products and proteolytic allergens.
TJs are composed of transmembrane proteins such as occludin
and the claudin family members that directly mediate cell–cell
adhesion and contribute to the development of the paracel-
lular barrier. These transmembrane constituents are clustered
and stabilized by cytosolic plaque proteins, such as ZO-1.
Changes in the expression of any one of these TJ components
can have significant effects on TJ integrity (Niessen, 2007). We
have observed reduced expression of CLDN1 and CLDN23 in
nonlesional skin from AD subjects where TJ function is
significantly impaired (De Benedetto et al., 2011). Silencing
of CLDN1 in human keratinocytes and in mice genetically
deficient in CLDN1 confirm the importance of this protein for
a competent TJ and skin barrier (Furuse et al., 2002; De
Benedetto et al., 2011). Results reported herein arose from
experiments designed to identify pathways that would
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expression level was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Mann–Whitney t-test). NOD2, nucleotide-binding oligomerization
domain-containing 2; PGLYRP-3, peptidoglycan recognition protein 3; PGLYRP-4, peptidoglycan recognition protein 4; RVU, relative value unit. *Po0.05;
NS, not significant.
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Figure 6. The reduced Toll-like receptor 2 (TLR2) expression observed in atopic dermatitis (AD) epithelium inversely correlates with measures of barrier
integrity. (a) Representative paraffin-embedded skin biopsy samples from a nonatopic healthy control (NA; n¼ 10), nonlesional AD (AD_NL; n¼ 13), and lesional
AD (AD_L; n¼ 13) subjects stained for TLR2 are shown. The white dotted lines denote the epidermal–dermal junction. Bar¼ 100mm. (b) Epidermal TLR2 staining
intensity is shown (Mann–Whitney t-test). (c) The line represents the linear least square fit for TLR2 epidermal staining intensity versus transepidermal water loss
(TEWL; Spearman’s nonparametric correlation (n¼ 25); r¼ 0.654, P¼0.0004). *Po0.05; ***Po0.001.
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enhance TJ function in the hope that these might be used to
repair AD barrier defects. We found that TJ function in
keratinocytes was enhanced by activation of the S. aureus–
responsive innate immune receptor, TLR2 (Figure 1). This
TLR2 activation was accompanied by increased expression of
several TJ components, including those that were reduced in
AD epidermis (CLDN1 and CLDN23; Figures 2 and 3).
Similarly, exfoliative toxin–negative S. aureus enhanced the
expression of TJ molecules (occludin and ZO-1) in human
keratinocytes, but had no effect on the adherens junction
proteins (Ohnemus et al., 2008), suggesting that TLR2-
mediated effects on TJ integrity in the skin are not mediated
by changes in the expression of other intercellular junctional
proteins. In keeping with these observations, we found that
Tlr2 / mouse had a delayed and incomplete repair response
to epidermal injury (Figure 4), suggesting that this innate
immune receptor mediates an important barrier repair path-
way that is likely operative in AD subjects who suffer from a
chronic itch/scratch cycle. This observation corroborates a
previous finding that dysregulation of the wound repair
response in skin might contribute to the severe phenotype in
patients with AD (Grigoryev et al., 2010). Furthermore, we
hypothesize that this repair pathway may be defective in AD
subjects who express less epidermal TLR2 than controls
(Figures 5 and 6). Collectively, these data establish a pre-
viously underappreciated role for innate receptors expressed
on epidermal cells in skin barrier maintenance and recovery.
Earlier studies demonstrated that Tlr2 / mice also develop
more severe intestinal disease in a dextran sulfate sodium–
mediated ulcerative colitis model, which was due to an
impaired intestinal TJ barrier repair response (Cario et al.,
2007). Importantly, Tlr4 / mice did not have the same
phenotype, suggesting that this was not a global TLR effect in
intestinal epithelial cells (Cario et al., 2007). In line with this
finding, our results indicate that TLR4 agonist, LPS, had no
effect on TEER in human keratinocytes (Figure 1e), which is
concordant with our unpublished data and that of other
groups demonstrating little to no TLR4 expression in human
keratinocytes (Baker et al., 2003; Kollisch et al., 2005).TLR3
ligands appeared to have an enhancing effect on TJ function,
but with tremendous variability from donor to donor
(Figure 1f). In contrast, we have shown that TLR3 induces TJ
disassembly in bronchial epithelium (Rezaee et al., 2011),
suggesting that the functions of these receptors may depend
more on the epithelial cell phenotype than the receptor itself.
Interestingly, S. aureus–derived LTA, which is considered an
activation through TLR2, had no effect on TJ function (Figures
1b and 2b), but did induce inflammatory gene expression in
human keratinocytes (Menzies and Kenoyer, 2006; Olaru and
Jensen, 2010). This suggests that the TLR2 signaling pathways
may be different for inflammatory mediator release versus TJ
barrier repair. It is also unclear whether LTA is a specific
ligand for TLR2 (Takeuchi et al., 1999; Schroder et al., 2003).
It has been shown that macrophages isolated from Tlr2 /
mice stimulated with LTA have similar induction of IL-6 and
TNF-a as compared with WT mice, whereas macrophages
from Tlr4 / mice stimulated with LTA have severely
impaired cytokine production (Takeuchi et al., 1999). This
suggests that LTA might act through TLR4. In our studies we
found that TLR4 had no effect on TJ function (Figure 1e), and
collectively this may explain why we observed no effect with
LTA stimulation.
To evaluate the biological relevance of TLR2 in skin barrier
repair, we evaluated Tlr2 / mice using an established
mechanical epidermal wound model (i.e., repetitive tape
tripping). Tape stripping liberates several danger-associated
molecular patterns, such as heat shock proteins and hyaluro-
nic acid, some of which are recognized as TLR2 ligands
(Schwandner et al., 1999; Yoshimura et al., 1999; Ozinsky
et al., 2000; Tsan and Gao, 2004; Dickel et al., 2010).
In addition, in this model, murine commensal bacteria may
activate epidermal TLR2. In this model, we observed that
Tlr2 / mice had a markedly delayed and incomplete barrier
recovery in response to a mechanically induced epidermal
wound as measured by TEWL, an in vivo measurement that
may reflect changes in either or both epidermal barrier
structures, SC and/or TJ (Figure 4d). We found that TLR2
agonists help repair epidermal barrier in human and WT mice
skin after tape stripping (Figure 4b, c, and e). To determine
whether TLR2 agonists are acting on epidermal TJs, we
developed a method to study human and murine epidermal
TJ function (i.e., TEER and paracellular flux) using the micro-
Snapwell system. We took advantage of the fact that
prolonged epidermal hydration (i.e., 24 hours) results in
disruption of intercellular lamellar lipid bilayers, degradation
of corneodesmosomes, and formation of amorphous regions
within the intercellular lipid (Warner et al., 1999, 2003),
which would arguably significantly compromise SC barrier
function. This observation, combined with the fact that the
skin samples had undergone repetitive tape stripping, led to
our assertion that we are primarily measuring TJ function in
this micro-Snapwell assay. We cannot entirely rule out the
possibility that this significantly disturbed SC may contribute
to our readouts, but we think that it is highly unlikely.
In summary, we have found that TLR2 agonists enhance TJ
functions in full-thickness epidermal samples from both mice
and humans that reaffirm our observations made in
keratinocyte monolayers. We observed a delay in barrier
repair in our Tlr2 / murine wound model, which is
explained at least in part to an impairment in TJ recovery.
We speculate that the enhanced expression of TLR2
observed in adjacent epidermal cells following barrier disrup-
tion (Schauber et al., 2007; Jin et al., 2009) serves two
purposes. The first is to respond to and contain pathogens
that proliferate in wounded skin. The second function is to
promote early TJ formation in keratinocytes that form a
monolayer over the dermal wound base. The early
formation of this TJ would prevent further serum leakage
and thereby limit the nutrients and adhesion molecules that
would promote microbial overgrowth and, additionally, this
would also minimize insensible water loss preventing wound
desiccation. We have observed that TLR2 is only expressed on
keratinocytes in the cellular layers below TJs (Yoshida, unpub-
lished data). Therefore, the development of a competent TJ
would also serve to limit TLR2-mediated inflammation that
might be harmful at these later stages of wound repair.
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Recently, Yuki et al. (2011b) found that adding TLR2
agonists to highly differentiated adult human keratinocytes
enhances TJ barrier function within 3 hours, but no change in
TJ protein expression was observed. There are several critical
differences in their methodology as compared with ours. They
used primary keratinocytes isolated from adult skin samples
and differentiated them in high calcium media (1.8 mM) for 4
days before treating with TLR2 agonist, whereas in our study,
we stimulated our neonatal primary keratinocytes with TLR2
ligands at the point the cells were placed in high calcium
media. Interestingly, we found that TLR2 agonists had little
effect when added to highly differentiated keratinocytes (Kuo,
unpublished data). This most likely reflects the reduced
expression of TLR2 observed in highly differentiated
keratinocytes (Supplementary Figure S6 online), and suggests
that TLR2 signaling has a major role not in a steady-state
maintenance of epidermal barrier integrity but rather in
epidermal repair. These methodological differences may
explain why they did not observe any changes in TJ protein
expression. In addition, we utilized both TEER measurement
and a paracellular flux assay, which is more sensitive to assess
changes in TJ integrity. Moreover, we evaluated this finding in
full-thickness human epidermis and murine skins, both of
which were wounded by tape stripping and observed this
same TLR2-mediated effect. Tape stripping is a model for the
chronic itch/scratch cycle commonly observed in subjects
with AD, and therefore our findings provide more direct
evidence that this is a clinically relevant effect. The other
discrepancy between our findings is that they observed that
LPS treatment (10mg ml1) induced TEER, whereas we used
lower doses of LPS (5–500 ng ml1) and did not observe an
effect on TJ function. It is worth noting that high concentra-
tions of LPS (1mg ml1) have been shown to induce TLR2
expression and its downstream signaling (NF-kB activation)
(Liu et al., 2001). In addition, the concentrations of both LTA
and PGN (ug range) as well as of LPS (ng range) we used in
our experiments are comparable when they are transposed to
bacterial equivalents. Based on this, the doses of LPS used
in the study of Yuki et al. (2011b) are potentially super-
physiologic. Therefore, it is possible that the TEER effect they
observed in LPS may be through TLR2 signaling.
Finally, keratinocytes from AD subjects have reduced
mRNA expression of TNF-a and IL-6 upon PGN stimulation
(Supplementary Figure S7 online). Interestingly, it has been
shown that Il-6 / mice (Wang et al., 2004) and Tnfr1 /
mice (Jensen et al., 1999) have delayed TEWL recovery after
tape stripping, suggesting that IL-6 and TNF-a might be critical
downstream mediators of TLR2-mediated skin barrier repair.
Studies are ongoing to understand the mechanism by which
TLR2 improves TJ barrier function. It is possible that the
reduced response to PGN observed in AD keratinocytes is
partly because of the reduced TLR2 expression observed in
AD epidermis (Figures 5 and 6a, b). This finding is also
consistent with the observation that TLR2 expression is
decreased in circulating monocytes from AD subjects
(Niebuhr et al., 2009; Antiga et al., 2011), suggesting that
AD subjects may have a genetic or epigenetic defect that
affects expression and/or function of TLR2 on multiple cell
types (Hasannejad et al., 2007; Mrabet-Dahbi et al., 2008;
Niebuhr et al., 2009; Antiga et al., 2011). Indeed, we
examined 11 haplotype-tagging single-nucleotide poly-
morphisms in the TLR2 gene, and found no association with
AD in two independent groups of patients with AD
(Caucasians: n¼ 258; African Americans: n¼ 176) and
healthy control subjects (n¼ 156; n¼ 152, respectively;
Barnes, unpublished data). This suggests that the observed
changes in TLR2 expression in AD subjects likely develop as
the consequence of local inflammatory mediators or on an
epigenetic basis. Recent reports indicate that several
microRNAs could inhibit TLR2 protein translation and
thereby decrease its expression and likely also its function
(Benakanakere et al., 2009; Liu et al., 2009; Jurkin et al., 2010;
Nahid et al., 2011). Studies are ongoing to evaluate this
important hypothesis.
In conclusion, keratinocytes provide the first line of defense
against microbes and dynamically respond to tissue injury.
This involves the production of a tightly orchestrated inflam-
matory response aimed at enhancing epidermal barrier recov-
ery and limiting microbial overgrowth. Our data demonstrate
that the innate immune function of the keratinocytes also
includes the preservation of TJ integrity. Therefore, in healthy
subjects, TLR2 will have a reparative effect on disrupted TJ,
and we hypothesize that this barrier protective response is
diminished in AD subjects who express less TLR2. Defective
TLR2 responses would also enable pathogenic bacteria, such
as S. aureus, to persist on the skin surface and perpetuate
inflammation. Strategies that boost TLR2 expression or func-
tion may hold promise in restoring epidermal integrity in AD.
MATERIALS AND METHODS
Transepithelial electric resistance
PHKs were isolated from discarded neonatal foreskins (also
see Supplementary Materials online). PHKs were plated in
K-SFM in 24-well Costar Transwell inserts (polyester mem-
branes, 0.4-mm pore size; Corning Life Sciences, Corning,
NY). After cells were confluent, media were switched to
DMEM media allowing PHK differentiation and TJ formation.
At the same time, TLR ligands were placed in upper wells for 8
days. Culture media was changed every other day. TEER was
measured as previously described (De Benedetto et al., 2011).
TEER absolute values at day 1 in control groups ranged from
87±15 to 305±120 ohms cm2. The study was approved by
the Research Subject Review Board at the University of
Rochester Medical Center and was conducted according to
the Declaration of Helsinki Principles.
Paracellular flux assay
PHKs were seeded in Transwell inserts and treated as
described above. After 48 hours, 0.02% fluorescein sodium
(Sigma-Aldrich, St Louis, MO) in phosphate-buffered saline
was added to the upper well, whereas phosphate-buffered
saline alone was added to the lower well. Samples were
collected from the lower well after 30 minutes. The amount of
fluorescein sodium (fluorescein) that diffused from across the
filter was measured with the iQ5 Multicolor real-time PCR
detection system (Bio-Rad, Hercules, CA). Paracellular flux
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was presented as follows: Paracellular flux (fold of control)¼
fluorescein intensity of treatment groups/fluorescein intensity
of control group.
Barrier disruption of murine skin
Age-matched (12–16 weeks old) female Tlr2 / mice
(C57BL6 background; kindly provided by Dr Jian-Dong Li)
(Shuto et al., 2002) and WT mice (C57BL6; purchased from
the National Cancer Institute, Bethesda, MD) were
anesthetized with ketamine/xylazine, back hair was shaved,
and depilatory applied for 3 minutes (Veet; Reckitt Benckiser,
Wayne, NJ) to completely remove all hair. To disrupt the skin
barrier, Cellotape (Nichiban, Tokyo, Japan) was pressed firmly
against the skin, removed, and repeated with a new piece
of tape each time until TEWL reached the same value
(B75±10 g h1 m2) on both mice, and then barrier
recovery was monitored by TEWL measurement (Tewameter
300; Courage-Khazaka Electronics, Koln, Germany) at 0, 1,
2, 3, and 24 hours. Animal experiments were approved by the
University Committee on Animal Resources at the University
of Rochester Medical Center.
Micro-Snapwell barrier function assay on ex vivo mouse and
human skin
The Snapwell system was used to measure TEER from human
and murine epidermis with and without exposure to the
TLR2 agonist, Pam3CSK4. The protocol used was a mod-
ification of one previously described (El Asmar et al., 2002).
In brief, skin from the back was harvested from mice,
immediately following tape stripping (time 0 hours), and
rinsed in phosphate-buffered saline. For human skin, full-
thickness epidermis was obtained from discarded skin
samples after 15 tape strippings, using a Weck blade
(Goulian Skin Graft Knife Set; George Tiemann,
Hauppauge, NY) and then rinsed in phosphate-buffered
saline. Skin samples were mounted on filter supports
(Whatman Nuclepore Track-Etch Membrane; GE
Healthcare Biosciences, Pittsburgh, PA) with the epidermal
side oriented upward and sandwiched between two sterile
Plexiglas discs (Rohm & Haas, Philadelphia, PA), with an
opening of 3 mm and placed in modified Snapwell chambers
(Corning, Corning, NY). Samples were submerged in DMEM
complete media and kept at 37 1C, 5% CO2 for 30 minutes.
Pam3CSK4 (10 mg ml1) or media alone were then added to
both sides of the transwell, and TEER was measured at 0 and
24 hours by using Endohm with a planar electrode (Endohm-
Snap; World Precision Instruments, Sarasota, FL). TEER
(ohms cm2)¼ (measured value) (transwell area; 0.07
cm2). The percentage change in TEER between time 0
(100%) and time 24 hours was expressed as follows:
(TEER24 hours/TEER0 hours)100. Data were normalized to
control group, and presented as fold of control.
Paracellular flux of fluorescein in human epidermis was
measured at 24 hours as described above. Using human
discarded skins was approved by the Research Subject
Review Board at the University of Rochester Medical
Center. This study was conducted according to the
Declaration of Helsinki Principles.
Statistical analysis
Data are expressed as mean±SEM and are representative of at
least three separate experiments. One-way or two-way analy-
sis of variance was used to determine significance unless
otherwise stated. Mann–Whitney t-test was used to compare
gene expression and immunofluorescence intensity between
AD and nonatopic skin. Spearman’s nonparametric correlation
was used to evaluate the correlation between TLR2 staining
intensity and TEWL. The statistical analysis was performed
using GraphPad Prism 5 (GraphPad Software, San Diego, CA).
Po0.05 was considered significant.
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